학술논문
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study
Document Type
Article
Author
Ozen, A.; Sefer, A.P.; Kolukisa, B.; Baris, S.; Karakoc-Aydiner, E.; Ergelen, R.; Suratannon, N.; Suphapeetiporn, K.; Chongsrisawat, V.; Jalbert, J.J.; Meagher, K.A.; Brackin, T.; Perlee, L.; Harari, O.A.; Yancopoulos, G.D.; Feldman, H.B.; Fuss, I.J.; Moorman, H.; Lenardo, M.J.; Miller, J.L.; Eshach Adiv, O.; Bilgic Eltan, S.; Yorgun Altunbas, M.; Magliocco, M.; Matthews, H.; Marciano, B.E.; Chatchatee, P.; Trbovic, C.F.; Burczynski, M.E.; Chaudhari, U.; Usta, Y.; Altuntaş, C.; Yavuz, S.; Baştürk, A.; Demirbaş Ar, F.; Topal, E.; Kalaycı, A.G.; Weerapakorn, W.; Calabi Martínez, A.A.; Bottero, A.
Source
In: The Lancet . (The Lancet, 17 February 2024, 403(10427):645-656)
Subject
Language
English
ISSN
1474547X
01406736
01406736